Checkpoint immunotherapy for NK/T cell lymphoma-Time for a showdown?

Jason Yongsheng ChanJing-Quan LimChoon Kiat Ong

Published in: Precision clinical medicine (2021)

A commentary on "Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma".

Keyphrases

nk cells
dna damage
diffuse large b cell lymphoma
cell cycle
cell proliferation